SEC Form 4 · accession 0001127602-17-010410

Medtronic plc · MDT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Hooman Hakami

Officer — EVP & Group President Diabetes

Period of report

Mar 2, 2017

Accepted (ET)

Mar 6, 2017 · 1:57 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001613103

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Ordinary Shares	Mar 2, 2017	M	14,871	$62.76	A	73,800	D
Ordinary Shares	Mar 2, 2017	M	797	$62.76	A	74,597	D
Ordinary Shares	Mar 2, 2017	M	36,648	$62.76	A	111,245	D
Ordinary Shares^F1,F2	Mar 2, 2017	S	52,316	$82.327	D	58,929	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$62.76	Mar 2, 2017	M	14,871	D	—	Jul 28, 2024	Ordinary Shares	14,871	89,762	D
Stock Option (Right to Buy)^F4	$62.76	Mar 2, 2017	M	797	D	—	Jul 28, 2024	Ordinary Shares	797	88,965	D
Stock Option (Right to Buy)^F5	$62.76	Mar 2, 2017	M	36,648	D	—	Jul 28, 2024	Ordinary Shares	36,648	52,317	D

Explanation of responses

F1The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.30 to $82.41, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2This balance increased by 627 shares due to exempt transactions such as dividend reinvestment.
F3This option to purchase 29,743 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 29,743 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
F4This option to purchase 1,594 ordinary shares of New Medtronic for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
F5This option to purchase 73,296 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 73,296 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.